Zobrazeno 1 - 10
of 1 031
pro vyhledávání: '"Cardiovascular Therapy"'
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 76-80 (2023)
The review outlines modern concepts of the relevance of fixed-dose combination therapy comprising angiotensin-converting enzyme inhibitor and dihydropyridine calcium channel antagonist as an antihypertensive component with the HMG-CoA reductase inhib
Externí odkaz:
https://doaj.org/article/7f5e1611256340d8adfa5d612c9bacab
Autor:
Rik S. van der Veen, Joseph J. Lee, Richard J. McManus, Richard F. D. Hobbs, Kamal R. Mahtani, Constantinos Koshiaris, James P. Sheppard
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-7 (2021)
Abstract Background Polypharmacy is inevitable and appropriate for many conditions, but in some cases, it can be problematic resulting in an increased risk of harm and reduced quality of life. There has been an increasing interest to reduce cardiopro
Externí odkaz:
https://doaj.org/article/ac8e8739aad64484b02f1b5701de3f74
Autor:
Domenico Maria Carretta, Aline Maria Silva, Donato D’Agostino, Skender Topi, Roberto Lovero, Ioannis Alexandros Charitos, Angelika Elzbieta Wegierska, Monica Montagnani, Luigi Santacroce
Publikováno v:
Infectious Disease Reports, Vol 13, Iss 2, Pp 494-517 (2021)
Background: The widely variable clinical manifestations of SARS-CoV2 disease (COVID-19) range from asymptomatic infections to multiple organ failure and death. Among the organs affected is the heart. This does not only affect people who already have
Externí odkaz:
https://doaj.org/article/1e5258b0404f4b6689ae67d358ac67c8
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Background and PurposeMultiple guidelines suggest the ω-3 polyunsaturated fatty acids (ω-3 PUFAs) help to prevent major vascular events of coronary heart disease (CHD), but the data on large trials of ω-3 fatty acids are controversial. We reviewed
Externí odkaz:
https://doaj.org/article/a2301e489b0d4eb3b2bacf4282c2b19c
Autor:
T. V. Pavlova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 1031-1038 (2020)
Anticoagulant therapy in elderly patients with atrial fibrillation and concomitant diseases is often the challenge for clinicians. The high risk of stroke is inherent in atrial fibrillation, and it increases when combined with coronary heart disease
Externí odkaz:
https://doaj.org/article/21df9723c1344b87898f43bd73623e66
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Selvaraj Jayaraman, Dhanavathy Gnanasampanthapandian, Johnson Rajasingh, Kanagaraj Palaniyandi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Owing to myocardial abnormalities, cardiac ailments are considered to be the major cause of morbidity and mortality worldwide. According to a recent study, membranous vesicles that are produced naturally, termed as “exosomes”, have emerged as the
Externí odkaz:
https://doaj.org/article/3b7500e0ec0a404ca19321b0bcc5795f
Autor:
Dan-Dominic IONESCU
Publikováno v:
Romanian Journal of Medical Practice, Vol 15, Iss 3, Pp 272-274 (2020)
Nattokinase is a fibrinolytic enzyme identified and isolated in 1987 from a specific Japanese food called natto (a kind of vegetable cheese). Since its discovery and until now, nattokinase has been studied experimentally and clinically almost exclusi
Externí odkaz:
https://doaj.org/article/ffd30def65ec4c53a6853d983ebc2339
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Anatolian Journal of Cardiology, Vol 25, Iss 11, Pp 753-761 (2021)
Anatol J Cardiol
Anatol J Cardiol
OBJECTIVE: In this study, we aimed to overview the drug interactions between colchicine and cardiovascular drugs and performed a meta-analysis to evaluate the safety profile of colchicine in cardiovascular treatment. METHODS: The drug interactions be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af839a696714475f0c4e3fec5a72572
https://anatoljcardiol.com/jvi.aspx?un=AJC-50305&volume=25&issue=11
https://anatoljcardiol.com/jvi.aspx?un=AJC-50305&volume=25&issue=11